2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
47
Gastrointestinal
42
Head & Neck
11
Gynecologic
11
Thoracic
10
Other hematologic neoplasm
9
Tumor-Agnostic
8
Genitourinary
6
Lymphoid
5
Endocrine
3
CNS
3
Sarcoma
2
Plasma cell
1
Other solid neoplasm
1
Other neoplasm
1
Other
1
NET
1
Dermatologic
1
Classical hematology
1
Conditions
Cervical Cancer Screening
1
Interventions
Cyclophosphamide
13
Biopsy
13
fludarabine phosphate
9
Whole-Body Irradiation
9
Surveys and Questionnaires
9
Peripheral Blood Stem Cell Transplantation
9
Busulfan
9
Polymerase Chain Reaction
7
Mycophenolic Acid
7
Early Intervention, Educational
7
Tacrolimus
6
Gene Expression Profiling
6
Educational Status
6
Colposcopy
6
Carboplatin
6
fludarabine
5
Paclitaxel
5
Microarray Analysis
5
Methotrexate
5
Methods
5
Melphalan
5
Immunohistochemistry
5
Epoetin Alfa
5
Decitabine
5
Cyclosporine
5
Cisplatin
5
Celecoxib
5
Antilymphocyte Serum
5
Aminolevulinic Acid
5
Sulindac
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Control Groups
×
Other neoplasm
×
Clear all
NCT06800664
2025-01-31
HOPE-inG
Baylor University
Phase NA
Not yet recruiting
1,500 enrolled